Michael P LaQuaglia
Overview
Explore the profile of Michael P LaQuaglia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
101
Citations
2452
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Conte B, Casey D, Tringale K, LaQuaglia M, Gerstle J, Wexler L, et al.
Pediatr Blood Cancer
. 2024 Mar;
71(6):e30949.
PMID: 38520048
Purpose: To evaluate local failure (LF) and toxicity after intraoperative radiation therapy (IORT) in pediatric solid tumors (ST). Methods: A single-institution retrospective study of 96 pediatric patients (108 applications) with...
2.
Conte B, Casey D, Tringale K, Honeyman J, Narayan N, LaQuaglia M, et al.
Pract Radiat Oncol
. 2024 Feb;
14(3):e226-e232.
PMID: 38310488
Purpose: To evaluate outcomes after intraoperative radiation therapy (IORT) in high-risk neuroblastoma (NB), including local control, overall survival, and toxicity. Methods And Materials: This was a single institution retrospective study...
3.
Shaffiey S, Le H, Christison-Lagay E, Fialkowski E, Aldrink J, Grant C, et al.
Semin Pediatr Surg
. 2023 Dec;
32(5):151338.
PMID: 38042090
Neuroblastoma (NB) is the most common solid extracranial malignancy of childhood with an incidence of 1 per 100,000 in the United States compromising approximately 10 % of childhood cancer. Unfortunately,...
4.
Lopez J, Subramanian T, Durell J, Levyn H, Wong R, Shah J, et al.
J Surg Oncol
. 2023 Oct;
129(2):219-223.
PMID: 37850570
Background: Neuroblastomas rarely occur as primary tumors in the cervical region. Therefore, very little has been reported regarding treatment strategies, complications, and outcomes of these cervical neuroblastomas. The goal of...
5.
Kushner B, LaQuaglia M, Cardenas F, Basu E, Gerstle J, Kramer K, et al.
Int J Cancer
. 2023 Aug;
153(12):2019-2031.
PMID: 37602920
Patients with stage 4N neuroblastoma (distant metastases limited to lymph nodes) stand out as virtually the only survivors of high-risk neuroblastoma (HR-NB) before myeloablative therapy (MAT) and immunotherapy with anti-G...
6.
Gundem G, Levine M, Roberts S, Cheung I, Medina-Martinez J, Feng Y, et al.
Nat Genet
. 2023 May;
55(6):1022-1033.
PMID: 37169874
Patients with high-risk neuroblastoma generally present with widely metastatic disease and often relapse despite intensive therapy. As most studies to date focused on diagnosis-relapse pairs, our understanding of the genetic...
7.
LaQuaglia M, Gerstle J
J Surg Oncol
. 2022 Sep;
126(5):933-942.
PMID: 36087080
In the United States, more than 10 000 cancers occur annually in children aged 0-14 years, and more than 5000 in adolescents aged 15-19. In the last 50 years, significant...
8.
Narayan N, Requena D, Lalazar G, Ramos-Espiritu L, Ng D, Levin S, et al.
Stem Cell Reports
. 2022 Jul;
17(8):1874-1888.
PMID: 35803261
Fibrolamellar carcinoma (FLC) is a rare, often lethal, liver cancer affecting adolescents and young adults, for which there are no approved therapeutics. The development of therapeutics is hampered by a...
9.
Lalazar G, Requena D, Ramos-Espiritu L, Ng D, Bhola P, de Jong Y, et al.
Cancer Discov
. 2021 Jun;
11(10):2544-2563.
PMID: 34127480
To repurpose therapeutics for fibrolamellar carcinoma (FLC), we developed and validated patient-derived xenografts (PDX) from surgical resections. Most agents used clinically and inhibitors of oncogenes overexpressed in FLC showed little...
10.
Rodriguez-Galindo C, Krailo M, Pinto E, Pashankar F, Weldon C, Huang L, et al.
J Clin Oncol
. 2021 Apr;
39(22):2463-2473.
PMID: 33822640
Purpose: Adrenocortical carcinoma (ACC) is a rare aggressive pediatric malignancy with distinct biology. Its treatment follows the principles developed for adults; pediatric-specific studies are scarce. Patients And Methods: Prospective single-arm...